Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Netazepide in Barrett's Esophagus
NCT02597712Phase 2Completed
- Sponsor
- Trio Medicines Ltd
- Start
- May 2013
- Primary completion
- Nov 2017
- Modality
- Allosteric Modulators
- Countries
- 2
01
Overview
A Phase 2 trial of netazepide in Barrett's esophagus, sponsored by Trio Medicines Ltd. Started May 2013; status: completed.
02
Drugs
netazepide
03
Conditions
Barrett's esophagus
Beyond the preview
Go deeper on NCT02597712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02597712.